Hospital success is evaluated through long-term patient survival and graft survival, which means how long the donor organ functions. International registries collect this outcome data to track hospital performance. Patients should request verified clinical survival statistics directly from hospital medical boards. Independent quality audits also provide objective measurements of surgical outcomes and postoperative infection controls.

Medical procedures cannot guarantee outcomes because individual healing responses and organ compatibility vary. A transplant restores renal function, which means kidney filtering ability, but requires ongoing management. Patients must take daily medication to prevent graft rejection, where the immune system attacks the organ. Success depends on following clinical advice, attending routine checkups, and maintaining healthy daily habits.

A transplanted kidney can function for many years depending on tissue matching and patient health. Living donor organs often last longer than deceased donor organs. Recipients must follow strict daily medication schedules to protect the new organ. Regular follow-up appointments help nephrologists, or kidney specialists, detect early signs of reduced organ performance.

Total costs depend on pre-transplant donor evaluation, hospital stay duration, and surgical complexity. Specialised laboratory tests, including HLA typing to check tissue compatibility, affect initial expenses. Post-operative care in intensive care units and necessary anti-rejection medications also contribute to overall charges. Patients should request itemised financial estimates covering surgeon fees, hospital charges, and medication needs.

Financial aid options exist through charitable trusts, government assistance schemes, and non-governmental health foundations. Hospital social service departments help eligible patients apply for available financial aid packages. Foreign travel insurance or international health policies may also cover specific medical costs. Patients should consult hospital administrative coordinators early to explore all potential assistance programs.

Pre-transplant evaluations require extensive blood tests, cardiac screening, antibody screening, and organ imaging scans. Crossmatching, which tests donor and recipient blood samples together, ensures biological compatibility. These diagnostic tests confirm the recipient is medically prepared for surgery. They also verify safety for immunosuppressive drugs, which prevent organ rejection. Complete evaluations help clinical teams plan effective post-transplant recovery care.

Tissue typing is a laboratory blood test that checks genetic markers between organ donors and recipients. Matching human leukocyte antigens, which are proteins on cells, reduces the risk of body organ rejection. Higher donor matching levels generally lead to better long-term kidney function. Transplant teams use these lab results to design appropriate post-surgery medication plans for patients.

Lifelong immunosuppression involves taking medications daily to calm the immune system. Without these medications, the body recognises the new kidney as foreign and attacks it. Taking prescribed anti-rejection drugs continuously protects the organ and maintains normal kidney function. Clinical teams monitor drug levels regularly through routine blood tests to prevent toxicity and maintain safety.

Graft rejection is monitored through regular blood tests, urine tests, and periodic ultrasound scans. Doctors measure serum creatinine, a blood waste product, to evaluate how well the kidney filters. Rising waste levels may indicate organ stress or rejection. If tests show potential issues, a renal biopsy confirms the diagnosis. A biopsy involves taking a small tissue sample for lab analysis.